Immunity against the opportunistic fungal pathogen Pneumocystis

Chad Steele1, Judd E Shellito, Jay K Kolls

  • 1Department of Pediatrics, Division of Pulmonology Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. chad.steele@chp.edu

Medical Mycology
|February 17, 2005
PubMed

Insights

Pneumocystis pneumonia remains a threat, especially breakthrough infections in immunocompromised patients. Host defense involves complex immune responses, highlighting the need for further research into fungal pathogen clearance.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Pneumocystis is an opportunistic fungal pathogen causing severe pneumonia in immunocompromised individuals.
  • Despite prophylaxis, breakthrough Pneumocystis infections are common, particularly in HIV patients and the immunocompromised.
  • Rising incidence in HIV-negative populations (transplant, hematologic malignancy patients) necessitates understanding host defense.

Purpose of the Study:

  • To investigate host defense mechanisms against Pneumocystis.
  • To understand the role of innate, cell-mediated, and humoral immunity in Pneumocystis infection.
  • To explore the balance between inflammation and immune clearance in the pulmonary environment.

Main Methods:

  • Review of clinical and experimental studies on host defense against Pneumocystis.
  • Analysis of immune responses (innate, T lymphocyte, B lymphocyte) in Pneumocystis infection.
  • Examination of the pulmonary inflammatory environment and its role in pathogenesis.

Main Results:

  • Host defense against Pneumocystis involves a coordinated effort of innate, T lymphocyte, and B lymphocyte responses.
  • The pulmonary environment's inflammatory response can contribute to Pneumocystis pathogenesis.
  • Clearance of Pneumocystis depends on balancing inflammation and immune-mediated clearance.

Conclusions:

  • Pneumocystis exhibits fungal characteristics, with immune responses similar to other fungal pathogens.
  • Understanding the immune equilibrium is crucial for managing Pneumocystis pneumonia.
  • Further research is needed to address breakthrough infections and optimize treatment strategies.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...